CASE REPORT. Membranoproliferative associated with type II in a renal transplant patient with hepatitis C. Glomerulonefrite membranoproliferativa em. Disease definition. Dense deposit disease, a histological subtype of MPGN (see this term) is an idiopathic chronic progressive kidney disorder distinguished by. Glomerulonefrite membranoproliferativa. Classificação Até achados estruturais e histopatológico fisiopatologia e.
|Published (Last):||22 November 2016|
|PDF File Size:||3.70 Mb|
|ePub File Size:||20.61 Mb|
|Price:||Free* [*Free Regsitration Required]|
Kidney Int Suppl ; Int J Nephrol ; doi: Iran J Kidney Dis ;4 1: Specialised Social Services Eurordis directory.
Rheumatology Oxford ;45 7: Clin J Am Soc Nephrol ;4 1: There have been several case reports and studies showing the effectiveness of Rituximab in the treatment of glomerular diseases, however, more randomized studies are needed 7,8,12,21, The patient did not receive any previous antiviral therapy.
Despite the presence of anti-HCV antibodies, the viral load remained undetectable. Hepatitis C virus infection and kidney transplantation: Recurrent membranoproliferative glomerulonephritis after kidney transplantation.
The most common HCV-related nephropathy is membranoproliferative glomerulonephritis MPGNusually in the context of cryoglobulinaemia 6,7. Telaprevir for previously untreated chronic hepatitis C virus infection.
He was treated with methylprednisolone pulses followed by oral prednisolone in association with rituximab. His baseline serum creatinine SCr was 1.
Rituximab induces regression of hepatitis C virus-related membranoproliferative in a renal allograft. The identification of the mechanisms that determine this racial difference represents an important question for future investigations.
Dense deposit disease, a histological subtype of MPGN see this term is an idiopathic chronic progressive kidney disorder distinguished by the presence of intra-membranous dense deposits in addition to immune complex subendothelial deposits in the glomerular capillary walls. We describe a case of membranoproliferative associated with type II in a renal transplant glomerulonnefrite with hepatitis C. According to KDIGO clinical practice guidelines oftreatment with interferon should be reserved to patients with fibrosing cholestatic hepatitis or life-threatening vasculitis Renal function progressively worsened to a maximum of SCr of 2.
Fabrizi F, Martin P, V.
He was admitted in the hospital for further investigation. Chronic hepatitis C virus infection in renal transplant: Disease definition Dense deposit disease, a histological subtype of MPGN see this term is an glmoerulonefrite chronic progressive kidney disorder distinguished by the presence of intra-membranous dense deposits in addition to immune complex subendothelial deposits in the glomerular capillary walls.
The HCV gllmerulonefrite an independent risk factor for graft loss and proteinuria after transplantation 4,5, Foi perdido o follow-up do doente.
Os memrbanoproliferativa antinuclear e anti-double stranded DNA foram negativos. Hepatitis C virus infection in nephrology patients. Health care resources for this disease Expert centres Diagnostic tests 12 Patient organisations 34 Orphan drug s 4.
The patient was lost for follow-up.
Orphanet: Glomerulonefrite membranoproliferativa tipo 2
To date, there are no studies of this therapy in renal transplant and randomized controlled trials are needed Am J Transplant ;1 2: Other glomerular diseases have also been reported, such as membranous nephropathy, minimal change disease, thrombotic microangiopathy, acute transplant glomerulopathy and chronic transplant glomerulopathies 1,4,5. The schedule and dosage recommended for this drug in renal transplant is not yet defined.
Kidney Int ;77 8: His maintenance immunosuppressive treatment consisted of tacrolimus AdvagrafR 5. Kidney Int ;54 2: The treatment with Rituximab allowed an membranoprolifertiva in renal function. Hepatitis C virus infection and de novo glomerular lesions in renal allografts.